nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—P-Glycoprotein Inhibitors—Everolimus—kidney cancer	0.575	1	CiPCiCtD
Telaprevir—ABCB1—kidney cancer	0.0938	1	CbGaD
Telaprevir—ORM1—Erlotinib—kidney cancer	0.0343	0.172	CbGbCtD
Telaprevir—ABCB1—Temsirolimus—kidney cancer	0.0202	0.101	CbGbCtD
Telaprevir—CYP3A4—Everolimus—kidney cancer	0.0179	0.0897	CbGbCtD
Telaprevir—ALB—Erlotinib—kidney cancer	0.0145	0.0725	CbGbCtD
Telaprevir—CYP3A4—Temsirolimus—kidney cancer	0.0121	0.0606	CbGbCtD
Telaprevir—ABCB1—Pazopanib—kidney cancer	0.0106	0.0531	CbGbCtD
Telaprevir—ABCB1—Dactinomycin—kidney cancer	0.00969	0.0486	CbGbCtD
Telaprevir—ABCB1—Gemcitabine—kidney cancer	0.00766	0.0384	CbGbCtD
Telaprevir—ABCB1—Erlotinib—kidney cancer	0.00756	0.0379	CbGbCtD
Telaprevir—ABCB1—Paclitaxel—kidney cancer	0.00692	0.0347	CbGbCtD
Telaprevir—CYP3A4—Pazopanib—kidney cancer	0.00635	0.0318	CbGbCtD
Telaprevir—ABCB1—Sorafenib—kidney cancer	0.00615	0.0308	CbGbCtD
Telaprevir—ABCB1—Vinblastine—kidney cancer	0.00607	0.0304	CbGbCtD
Telaprevir—ABCB1—Vincristine—kidney cancer	0.00597	0.0299	CbGbCtD
Telaprevir—ABCB1—Sunitinib—kidney cancer	0.00498	0.025	CbGbCtD
Telaprevir—CYP3A4—Erlotinib—kidney cancer	0.00453	0.0227	CbGbCtD
Telaprevir—CYP3A4—Paclitaxel—kidney cancer	0.00415	0.0208	CbGbCtD
Telaprevir—ABCB1—Doxorubicin—kidney cancer	0.00373	0.0187	CbGbCtD
Telaprevir—CYP3A4—Sorafenib—kidney cancer	0.00368	0.0185	CbGbCtD
Telaprevir—CYP3A4—Vinblastine—kidney cancer	0.00364	0.0182	CbGbCtD
Telaprevir—CYP3A4—Vincristine—kidney cancer	0.00357	0.0179	CbGbCtD
Telaprevir—CYP3A4—Sunitinib—kidney cancer	0.00298	0.015	CbGbCtD
Telaprevir—CYP3A4—Doxorubicin—kidney cancer	0.00223	0.0112	CbGbCtD
Telaprevir—CTSK—renal system—kidney cancer	0.000654	0.109	CbGeAlD
Telaprevir—CTSK—kidney—kidney cancer	0.000632	0.105	CbGeAlD
Telaprevir—Boceprevir—ABCB1—kidney cancer	0.000629	1	CrCbGaD
Telaprevir—CTSK—gonad—kidney cancer	0.000587	0.0977	CbGeAlD
Telaprevir—CTSK—cardiac atrium—kidney cancer	0.000586	0.0976	CbGeAlD
Telaprevir—CYP3A4—urine—kidney cancer	0.000584	0.0973	CbGeAlD
Telaprevir—CTSS—renal system—kidney cancer	0.000573	0.0955	CbGeAlD
Telaprevir—CTSS—kidney—kidney cancer	0.000554	0.0923	CbGeAlD
Telaprevir—CTSS—cortex of kidney—kidney cancer	0.00054	0.0899	CbGeAlD
Telaprevir—CTSS—gonad—kidney cancer	0.000514	0.0856	CbGeAlD
Telaprevir—Stevens-Johnson syndrome—Gemcitabine—kidney cancer	0.000145	0.0017	CcSEcCtD
Telaprevir—Dysgeusia—Sorafenib—kidney cancer	0.000145	0.0017	CcSEcCtD
Telaprevir—Loss of consciousness—Erlotinib—kidney cancer	0.000145	0.0017	CcSEcCtD
Telaprevir—Hypokalaemia—Paclitaxel—kidney cancer	0.000145	0.0017	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Everolimus—kidney cancer	0.000144	0.0017	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Paclitaxel—kidney cancer	0.000143	0.00168	CcSEcCtD
Telaprevir—CYP3A4—renal system—kidney cancer	0.000143	0.0238	CbGeAlD
Telaprevir—Malnutrition—Sunitinib—kidney cancer	0.000143	0.00167	CcSEcCtD
Telaprevir—Renal failure acute—Capecitabine—kidney cancer	0.000141	0.00166	CcSEcCtD
Telaprevir—Dysgeusia—Sunitinib—kidney cancer	0.00014	0.00164	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—kidney cancer	0.000139	0.00164	CcSEcCtD
Telaprevir—Hepatobiliary disease—Gemcitabine—kidney cancer	0.000138	0.00163	CcSEcCtD
Telaprevir—Infection—Everolimus—kidney cancer	0.000138	0.00163	CcSEcCtD
Telaprevir—CYP3A4—kidney—kidney cancer	0.000138	0.023	CbGeAlD
Telaprevir—Shock—Everolimus—kidney cancer	0.000137	0.00161	CcSEcCtD
Telaprevir—Anaemia—Sorafenib—kidney cancer	0.000137	0.00161	CcSEcCtD
Telaprevir—Thrombocytopenia—Vinblastine—kidney cancer	0.000137	0.00161	CcSEcCtD
Telaprevir—Urinary tract disorder—Vincristine—kidney cancer	0.000137	0.00161	CcSEcCtD
Telaprevir—Nervous system disorder—Everolimus—kidney cancer	0.000137	0.0016	CcSEcCtD
Telaprevir—Thrombocytopenia—Everolimus—kidney cancer	0.000136	0.0016	CcSEcCtD
Telaprevir—Urethral disorder—Vincristine—kidney cancer	0.000136	0.00159	CcSEcCtD
Telaprevir—Skin disorder—Everolimus—kidney cancer	0.000135	0.00159	CcSEcCtD
Telaprevir—Asthenia—Temsirolimus—kidney cancer	0.000134	0.00158	CcSEcCtD
Telaprevir—Infection—Erlotinib—kidney cancer	0.000134	0.00157	CcSEcCtD
Telaprevir—Syncope—Sorafenib—kidney cancer	0.000133	0.00156	CcSEcCtD
Telaprevir—Pruritus—Temsirolimus—kidney cancer	0.000133	0.00156	CcSEcCtD
Telaprevir—Shock—Erlotinib—kidney cancer	0.000132	0.00155	CcSEcCtD
Telaprevir—Nervous system disorder—Erlotinib—kidney cancer	0.000132	0.00155	CcSEcCtD
Telaprevir—Anaemia—Sunitinib—kidney cancer	0.000132	0.00155	CcSEcCtD
Telaprevir—Thrombocytopenia—Erlotinib—kidney cancer	0.000132	0.00155	CcSEcCtD
Telaprevir—Skin disorder—Erlotinib—kidney cancer	0.000131	0.00153	CcSEcCtD
Telaprevir—Loss of consciousness—Sorafenib—kidney cancer	0.00013	0.00153	CcSEcCtD
Telaprevir—Urinary tract disorder—Gemcitabine—kidney cancer	0.00013	0.00152	CcSEcCtD
Telaprevir—Oedema peripheral—Gemcitabine—kidney cancer	0.000129	0.00152	CcSEcCtD
Telaprevir—Urethral disorder—Gemcitabine—kidney cancer	0.000129	0.00151	CcSEcCtD
Telaprevir—Rectal haemorrhage—Doxorubicin—kidney cancer	0.000128	0.00151	CcSEcCtD
Telaprevir—Diarrhoea—Temsirolimus—kidney cancer	0.000128	0.00151	CcSEcCtD
Telaprevir—Hyperbilirubinaemia—Doxorubicin—kidney cancer	0.000127	0.0015	CcSEcCtD
Telaprevir—Asthenia—Pazopanib—kidney cancer	0.000127	0.00149	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.000125	0.00147	CcSEcCtD
Telaprevir—Hyperuricaemia—Doxorubicin—kidney cancer	0.000125	0.00147	CcSEcCtD
Telaprevir—Pruritus—Pazopanib—kidney cancer	0.000125	0.00147	CcSEcCtD
Telaprevir—Anaemia—Dactinomycin—kidney cancer	0.000125	0.00147	CcSEcCtD
Telaprevir—Erythema multiforme—Gemcitabine—kidney cancer	0.000124	0.00146	CcSEcCtD
Telaprevir—Dizziness—Temsirolimus—kidney cancer	0.000124	0.00145	CcSEcCtD
Telaprevir—Infestation NOS—Paclitaxel—kidney cancer	0.000123	0.00144	CcSEcCtD
Telaprevir—Infestation—Paclitaxel—kidney cancer	0.000123	0.00144	CcSEcCtD
Telaprevir—Blood creatinine increased—Capecitabine—kidney cancer	0.000122	0.00144	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.000122	0.00143	CcSEcCtD
Telaprevir—Diarrhoea—Pazopanib—kidney cancer	0.000121	0.00142	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.000121	0.00142	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Everolimus—kidney cancer	0.00012	0.00141	CcSEcCtD
Telaprevir—Infection—Sorafenib—kidney cancer	0.00012	0.00141	CcSEcCtD
Telaprevir—Fatigue—Everolimus—kidney cancer	0.00012	0.00141	CcSEcCtD
Telaprevir—Vomiting—Temsirolimus—kidney cancer	0.000119	0.0014	CcSEcCtD
Telaprevir—Shock—Sorafenib—kidney cancer	0.000119	0.0014	CcSEcCtD
Telaprevir—Hypokalaemia—Capecitabine—kidney cancer	0.000119	0.0014	CcSEcCtD
Telaprevir—Nervous system disorder—Sorafenib—kidney cancer	0.000119	0.00139	CcSEcCtD
Telaprevir—Thrombocytopenia—Sorafenib—kidney cancer	0.000118	0.00139	CcSEcCtD
Telaprevir—Rash—Temsirolimus—kidney cancer	0.000118	0.00139	CcSEcCtD
Telaprevir—Blood uric acid increased—Doxorubicin—kidney cancer	0.000118	0.00139	CcSEcCtD
Telaprevir—Dermatitis—Temsirolimus—kidney cancer	0.000118	0.00139	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Capecitabine—kidney cancer	0.000118	0.00138	CcSEcCtD
Telaprevir—Skin disorder—Sorafenib—kidney cancer	0.000117	0.00138	CcSEcCtD
Telaprevir—Dizziness—Pazopanib—kidney cancer	0.000117	0.00137	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000116	0.00136	CcSEcCtD
Telaprevir—Hepatobiliary disease—Paclitaxel—kidney cancer	0.000116	0.00136	CcSEcCtD
Telaprevir—Fatigue—Erlotinib—kidney cancer	0.000116	0.00136	CcSEcCtD
Telaprevir—Infection—Sunitinib—kidney cancer	0.000116	0.00136	CcSEcCtD
Telaprevir—Shock—Sunitinib—kidney cancer	0.000115	0.00134	CcSEcCtD
Telaprevir—Nervous system disorder—Sunitinib—kidney cancer	0.000114	0.00134	CcSEcCtD
Telaprevir—Thrombocytopenia—Sunitinib—kidney cancer	0.000114	0.00134	CcSEcCtD
Telaprevir—Skin disorder—Sunitinib—kidney cancer	0.000113	0.00133	CcSEcCtD
Telaprevir—Vomiting—Pazopanib—kidney cancer	0.000112	0.00132	CcSEcCtD
Telaprevir—Anaemia—Vincristine—kidney cancer	0.000111	0.00131	CcSEcCtD
Telaprevir—Rash—Pazopanib—kidney cancer	0.000111	0.00131	CcSEcCtD
Telaprevir—Nausea—Temsirolimus—kidney cancer	0.000111	0.00131	CcSEcCtD
Telaprevir—ABCB1—nephron tubule—kidney cancer	0.000111	0.0185	CbGeAlD
Telaprevir—Dermatitis—Pazopanib—kidney cancer	0.000111	0.00131	CcSEcCtD
Telaprevir—Candida infection—Doxorubicin—kidney cancer	0.000111	0.0013	CcSEcCtD
Telaprevir—Infection—Dactinomycin—kidney cancer	0.000109	0.00129	CcSEcCtD
Telaprevir—Urinary tract disorder—Paclitaxel—kidney cancer	0.000109	0.00128	CcSEcCtD
Telaprevir—Oedema peripheral—Paclitaxel—kidney cancer	0.000108	0.00127	CcSEcCtD
Telaprevir—Urethral disorder—Paclitaxel—kidney cancer	0.000108	0.00127	CcSEcCtD
Telaprevir—Thrombocytopenia—Dactinomycin—kidney cancer	0.000108	0.00127	CcSEcCtD
Telaprevir—Anaemia—Gemcitabine—kidney cancer	0.000106	0.00124	CcSEcCtD
Telaprevir—Nausea—Pazopanib—kidney cancer	0.000105	0.00123	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000104	0.00123	CcSEcCtD
Telaprevir—Fatigue—Sorafenib—kidney cancer	0.000104	0.00122	CcSEcCtD
Telaprevir—Erythema multiforme—Paclitaxel—kidney cancer	0.000104	0.00122	CcSEcCtD
Telaprevir—Eye disorder—Paclitaxel—kidney cancer	0.000103	0.00121	CcSEcCtD
Telaprevir—ABCB1—renal system—kidney cancer	0.000101	0.0168	CbGeAlD
Telaprevir—Infestation NOS—Capecitabine—kidney cancer	0.000101	0.00118	CcSEcCtD
Telaprevir—Infestation—Capecitabine—kidney cancer	0.000101	0.00118	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Sunitinib—kidney cancer	0.0001	0.00118	CcSEcCtD
Telaprevir—Asthenia—Vinblastine—kidney cancer	0.0001	0.00118	CcSEcCtD
Telaprevir—Fatigue—Sunitinib—kidney cancer	0.0001	0.00118	CcSEcCtD
Telaprevir—Asthenia—Everolimus—kidney cancer	0.0001	0.00117	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Capecitabine—kidney cancer	9.97e-05	0.00117	CcSEcCtD
Telaprevir—Pruritus—Everolimus—kidney cancer	9.86e-05	0.00116	CcSEcCtD
Telaprevir—Infection—Vincristine—kidney cancer	9.78e-05	0.00115	CcSEcCtD
Telaprevir—ABCB1—kidney—kidney cancer	9.78e-05	0.0163	CbGeAlD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	9.67e-05	0.00114	CcSEcCtD
Telaprevir—Nervous system disorder—Vincristine—kidney cancer	9.65e-05	0.00113	CcSEcCtD
Telaprevir—Asthenia—Erlotinib—kidney cancer	9.65e-05	0.00113	CcSEcCtD
Telaprevir—Thrombocytopenia—Vincristine—kidney cancer	9.64e-05	0.00113	CcSEcCtD
Telaprevir—Urticaria—Sorafenib—kidney cancer	9.61e-05	0.00113	CcSEcCtD
Telaprevir—Malnutrition—Paclitaxel—kidney cancer	9.58e-05	0.00112	CcSEcCtD
Telaprevir—Diarrhoea—Vinblastine—kidney cancer	9.57e-05	0.00112	CcSEcCtD
Telaprevir—Diarrhoea—Everolimus—kidney cancer	9.53e-05	0.00112	CcSEcCtD
Telaprevir—ABCB1—cortex of kidney—kidney cancer	9.52e-05	0.0159	CbGeAlD
Telaprevir—Hepatobiliary disease—Capecitabine—kidney cancer	9.51e-05	0.00112	CcSEcCtD
Telaprevir—Pruritus—Erlotinib—kidney cancer	9.51e-05	0.00112	CcSEcCtD
Telaprevir—Fatigue—Dactinomycin—kidney cancer	9.5e-05	0.00112	CcSEcCtD
Telaprevir—Dysgeusia—Paclitaxel—kidney cancer	9.38e-05	0.0011	CcSEcCtD
Telaprevir—Eczema—Doxorubicin—kidney cancer	9.36e-05	0.0011	CcSEcCtD
Telaprevir—Infection—Gemcitabine—kidney cancer	9.28e-05	0.00109	CcSEcCtD
Telaprevir—Dizziness—Vinblastine—kidney cancer	9.25e-05	0.00109	CcSEcCtD
Telaprevir—Dizziness—Everolimus—kidney cancer	9.21e-05	0.00108	CcSEcCtD
Telaprevir—Diarrhoea—Erlotinib—kidney cancer	9.2e-05	0.00108	CcSEcCtD
Telaprevir—Nervous system disorder—Gemcitabine—kidney cancer	9.16e-05	0.00108	CcSEcCtD
Telaprevir—Thrombocytopenia—Gemcitabine—kidney cancer	9.14e-05	0.00107	CcSEcCtD
Telaprevir—Renal failure acute—Doxorubicin—kidney cancer	9.11e-05	0.00107	CcSEcCtD
Telaprevir—Skin disorder—Gemcitabine—kidney cancer	9.07e-05	0.00107	CcSEcCtD
Telaprevir—ABCB1—gonad—kidney cancer	9.07e-05	0.0151	CbGeAlD
Telaprevir—Urinary tract disorder—Capecitabine—kidney cancer	8.92e-05	0.00105	CcSEcCtD
Telaprevir—Oedema peripheral—Capecitabine—kidney cancer	8.9e-05	0.00104	CcSEcCtD
Telaprevir—Vomiting—Vinblastine—kidney cancer	8.89e-05	0.00104	CcSEcCtD
Telaprevir—Dizziness—Erlotinib—kidney cancer	8.89e-05	0.00104	CcSEcCtD
Telaprevir—Vomiting—Everolimus—kidney cancer	8.86e-05	0.00104	CcSEcCtD
Telaprevir—Anaemia—Paclitaxel—kidney cancer	8.85e-05	0.00104	CcSEcCtD
Telaprevir—Urethral disorder—Capecitabine—kidney cancer	8.85e-05	0.00104	CcSEcCtD
Telaprevir—Rash—Everolimus—kidney cancer	8.79e-05	0.00103	CcSEcCtD
Telaprevir—Dermatitis—Everolimus—kidney cancer	8.78e-05	0.00103	CcSEcCtD
Telaprevir—Asthenia—Sorafenib—kidney cancer	8.68e-05	0.00102	CcSEcCtD
Telaprevir—Syncope—Paclitaxel—kidney cancer	8.59e-05	0.00101	CcSEcCtD
Telaprevir—Pruritus—Sorafenib—kidney cancer	8.56e-05	0.001	CcSEcCtD
Telaprevir—Vomiting—Erlotinib—kidney cancer	8.55e-05	0.001	CcSEcCtD
Telaprevir—Erythema multiforme—Capecitabine—kidney cancer	8.54e-05	0.001	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Vincristine—kidney cancer	8.5e-05	0.000998	CcSEcCtD
Telaprevir—Fatigue—Vincristine—kidney cancer	8.49e-05	0.000997	CcSEcCtD
Telaprevir—Rash—Erlotinib—kidney cancer	8.48e-05	0.000995	CcSEcCtD
Telaprevir—Dermatitis—Erlotinib—kidney cancer	8.47e-05	0.000995	CcSEcCtD
Telaprevir—Eye disorder—Capecitabine—kidney cancer	8.44e-05	0.000991	CcSEcCtD
Telaprevir—Loss of consciousness—Paclitaxel—kidney cancer	8.42e-05	0.000989	CcSEcCtD
Telaprevir—Asthenia—Sunitinib—kidney cancer	8.35e-05	0.000981	CcSEcCtD
Telaprevir—Nausea—Vinblastine—kidney cancer	8.31e-05	0.000976	CcSEcCtD
Telaprevir—Nausea—Everolimus—kidney cancer	8.28e-05	0.000972	CcSEcCtD
Telaprevir—Diarrhoea—Sorafenib—kidney cancer	8.28e-05	0.000972	CcSEcCtD
Telaprevir—Pruritus—Sunitinib—kidney cancer	8.23e-05	0.000967	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	8.1e-05	0.000951	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Gemcitabine—kidney cancer	8.06e-05	0.000947	CcSEcCtD
Telaprevir—Fatigue—Gemcitabine—kidney cancer	8.05e-05	0.000945	CcSEcCtD
Telaprevir—Dizziness—Sorafenib—kidney cancer	8e-05	0.000939	CcSEcCtD
Telaprevir—Nausea—Erlotinib—kidney cancer	7.99e-05	0.000938	CcSEcCtD
Telaprevir—Diarrhoea—Sunitinib—kidney cancer	7.96e-05	0.000935	CcSEcCtD
Telaprevir—Asthenia—Dactinomycin—kidney cancer	7.91e-05	0.000928	CcSEcCtD
Telaprevir—Blood creatinine increased—Doxorubicin—kidney cancer	7.88e-05	0.000926	CcSEcCtD
Telaprevir—Malnutrition—Capecitabine—kidney cancer	7.86e-05	0.000923	CcSEcCtD
Telaprevir—Infection—Paclitaxel—kidney cancer	7.77e-05	0.000912	CcSEcCtD
Telaprevir—Dysgeusia—Capecitabine—kidney cancer	7.7e-05	0.000904	CcSEcCtD
Telaprevir—Dizziness—Sunitinib—kidney cancer	7.7e-05	0.000904	CcSEcCtD
Telaprevir—Shock—Paclitaxel—kidney cancer	7.69e-05	0.000903	CcSEcCtD
Telaprevir—Vomiting—Sorafenib—kidney cancer	7.69e-05	0.000903	CcSEcCtD
Telaprevir—Nervous system disorder—Paclitaxel—kidney cancer	7.67e-05	0.0009	CcSEcCtD
Telaprevir—Hypokalaemia—Doxorubicin—kidney cancer	7.66e-05	0.000899	CcSEcCtD
Telaprevir—Thrombocytopenia—Paclitaxel—kidney cancer	7.66e-05	0.000899	CcSEcCtD
Telaprevir—Rash—Sorafenib—kidney cancer	7.63e-05	0.000896	CcSEcCtD
Telaprevir—Dermatitis—Sorafenib—kidney cancer	7.62e-05	0.000895	CcSEcCtD
Telaprevir—Skin disorder—Paclitaxel—kidney cancer	7.59e-05	0.000892	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	7.58e-05	0.00089	CcSEcCtD
Telaprevir—Diarrhoea—Dactinomycin—kidney cancer	7.54e-05	0.000885	CcSEcCtD
Telaprevir—Vomiting—Sunitinib—kidney cancer	7.4e-05	0.000869	CcSEcCtD
Telaprevir—Rash—Sunitinib—kidney cancer	7.34e-05	0.000862	CcSEcCtD
Telaprevir—Dermatitis—Sunitinib—kidney cancer	7.33e-05	0.000861	CcSEcCtD
Telaprevir—Anaemia—Capecitabine—kidney cancer	7.27e-05	0.000853	CcSEcCtD
Telaprevir—Eosinophilia—Doxorubicin—kidney cancer	7.2e-05	0.000846	CcSEcCtD
Telaprevir—Nausea—Sorafenib—kidney cancer	7.18e-05	0.000844	CcSEcCtD
Telaprevir—Asthenia—Vincristine—kidney cancer	7.06e-05	0.000829	CcSEcCtD
Telaprevir—Syncope—Capecitabine—kidney cancer	7.05e-05	0.000828	CcSEcCtD
Telaprevir—Vomiting—Dactinomycin—kidney cancer	7.01e-05	0.000823	CcSEcCtD
Telaprevir—Rash—Dactinomycin—kidney cancer	6.95e-05	0.000816	CcSEcCtD
Telaprevir—Nausea—Sunitinib—kidney cancer	6.91e-05	0.000812	CcSEcCtD
Telaprevir—Loss of consciousness—Capecitabine—kidney cancer	6.91e-05	0.000811	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Paclitaxel—kidney cancer	6.75e-05	0.000793	CcSEcCtD
Telaprevir—Fatigue—Paclitaxel—kidney cancer	6.74e-05	0.000792	CcSEcCtD
Telaprevir—Diarrhoea—Vincristine—kidney cancer	6.74e-05	0.000791	CcSEcCtD
Telaprevir—Asthenia—Gemcitabine—kidney cancer	6.7e-05	0.000787	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	6.65e-05	0.000781	CcSEcCtD
Telaprevir—Pruritus—Gemcitabine—kidney cancer	6.61e-05	0.000776	CcSEcCtD
Telaprevir—Nausea—Dactinomycin—kidney cancer	6.54e-05	0.000769	CcSEcCtD
Telaprevir—Dizziness—Vincristine—kidney cancer	6.51e-05	0.000764	CcSEcCtD
Telaprevir—Infestation—Doxorubicin—kidney cancer	6.48e-05	0.000762	CcSEcCtD
Telaprevir—Infestation NOS—Doxorubicin—kidney cancer	6.48e-05	0.000762	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	6.43e-05	0.000755	CcSEcCtD
Telaprevir—Diarrhoea—Gemcitabine—kidney cancer	6.39e-05	0.00075	CcSEcCtD
Telaprevir—Infection—Capecitabine—kidney cancer	6.37e-05	0.000749	CcSEcCtD
Telaprevir—Shock—Capecitabine—kidney cancer	6.31e-05	0.000741	CcSEcCtD
Telaprevir—Nervous system disorder—Capecitabine—kidney cancer	6.29e-05	0.000739	CcSEcCtD
Telaprevir—Thrombocytopenia—Capecitabine—kidney cancer	6.28e-05	0.000738	CcSEcCtD
Telaprevir—Vomiting—Vincristine—kidney cancer	6.26e-05	0.000735	CcSEcCtD
Telaprevir—Skin disorder—Capecitabine—kidney cancer	6.23e-05	0.000732	CcSEcCtD
Telaprevir—Urticaria—Paclitaxel—kidney cancer	6.21e-05	0.000729	CcSEcCtD
Telaprevir—Rash—Vincristine—kidney cancer	6.21e-05	0.000729	CcSEcCtD
Telaprevir—Dermatitis—Vincristine—kidney cancer	6.2e-05	0.000728	CcSEcCtD
Telaprevir—Hepatobiliary disease—Doxorubicin—kidney cancer	6.13e-05	0.00072	CcSEcCtD
Telaprevir—Vomiting—Gemcitabine—kidney cancer	5.94e-05	0.000697	CcSEcCtD
Telaprevir—Rash—Gemcitabine—kidney cancer	5.89e-05	0.000691	CcSEcCtD
Telaprevir—Dermatitis—Gemcitabine—kidney cancer	5.88e-05	0.000691	CcSEcCtD
Telaprevir—Nausea—Vincristine—kidney cancer	5.85e-05	0.000687	CcSEcCtD
Telaprevir—Urinary tract disorder—Doxorubicin—kidney cancer	5.75e-05	0.000675	CcSEcCtD
Telaprevir—Oedema peripheral—Doxorubicin—kidney cancer	5.73e-05	0.000673	CcSEcCtD
Telaprevir—Urethral disorder—Doxorubicin—kidney cancer	5.71e-05	0.00067	CcSEcCtD
Telaprevir—Asthenia—Paclitaxel—kidney cancer	5.61e-05	0.000659	CcSEcCtD
Telaprevir—Nausea—Gemcitabine—kidney cancer	5.55e-05	0.000651	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Capecitabine—kidney cancer	5.54e-05	0.00065	CcSEcCtD
Telaprevir—Fatigue—Capecitabine—kidney cancer	5.53e-05	0.00065	CcSEcCtD
Telaprevir—Pruritus—Paclitaxel—kidney cancer	5.53e-05	0.00065	CcSEcCtD
Telaprevir—Erythema multiforme—Doxorubicin—kidney cancer	5.5e-05	0.000646	CcSEcCtD
Telaprevir—Eye disorder—Doxorubicin—kidney cancer	5.44e-05	0.000639	CcSEcCtD
Telaprevir—Diarrhoea—Paclitaxel—kidney cancer	5.35e-05	0.000628	CcSEcCtD
Telaprevir—Dizziness—Paclitaxel—kidney cancer	5.17e-05	0.000607	CcSEcCtD
Telaprevir—Urticaria—Capecitabine—kidney cancer	5.1e-05	0.000599	CcSEcCtD
Telaprevir—Malnutrition—Doxorubicin—kidney cancer	5.07e-05	0.000595	CcSEcCtD
Telaprevir—Vomiting—Paclitaxel—kidney cancer	4.97e-05	0.000584	CcSEcCtD
Telaprevir—Dysgeusia—Doxorubicin—kidney cancer	4.96e-05	0.000583	CcSEcCtD
Telaprevir—Rash—Paclitaxel—kidney cancer	4.93e-05	0.000579	CcSEcCtD
Telaprevir—Dermatitis—Paclitaxel—kidney cancer	4.93e-05	0.000578	CcSEcCtD
Telaprevir—Anaemia—Doxorubicin—kidney cancer	4.68e-05	0.00055	CcSEcCtD
Telaprevir—Nausea—Paclitaxel—kidney cancer	4.64e-05	0.000545	CcSEcCtD
Telaprevir—Asthenia—Capecitabine—kidney cancer	4.6e-05	0.000541	CcSEcCtD
Telaprevir—Syncope—Doxorubicin—kidney cancer	4.54e-05	0.000534	CcSEcCtD
Telaprevir—Pruritus—Capecitabine—kidney cancer	4.54e-05	0.000533	CcSEcCtD
Telaprevir—Loss of consciousness—Doxorubicin—kidney cancer	4.45e-05	0.000523	CcSEcCtD
Telaprevir—Diarrhoea—Capecitabine—kidney cancer	4.39e-05	0.000516	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	4.28e-05	0.000503	CcSEcCtD
Telaprevir—Dizziness—Capecitabine—kidney cancer	4.24e-05	0.000498	CcSEcCtD
Telaprevir—Infection—Doxorubicin—kidney cancer	4.11e-05	0.000483	CcSEcCtD
Telaprevir—Vomiting—Capecitabine—kidney cancer	4.08e-05	0.000479	CcSEcCtD
Telaprevir—Shock—Doxorubicin—kidney cancer	4.07e-05	0.000478	CcSEcCtD
Telaprevir—Nervous system disorder—Doxorubicin—kidney cancer	4.06e-05	0.000476	CcSEcCtD
Telaprevir—Thrombocytopenia—Doxorubicin—kidney cancer	4.05e-05	0.000476	CcSEcCtD
Telaprevir—Rash—Capecitabine—kidney cancer	4.05e-05	0.000475	CcSEcCtD
Telaprevir—Dermatitis—Capecitabine—kidney cancer	4.04e-05	0.000475	CcSEcCtD
Telaprevir—Skin disorder—Doxorubicin—kidney cancer	4.02e-05	0.000472	CcSEcCtD
Telaprevir—Nausea—Capecitabine—kidney cancer	3.81e-05	0.000448	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Doxorubicin—kidney cancer	3.57e-05	0.000419	CcSEcCtD
Telaprevir—Fatigue—Doxorubicin—kidney cancer	3.57e-05	0.000419	CcSEcCtD
Telaprevir—Urticaria—Doxorubicin—kidney cancer	3.29e-05	0.000386	CcSEcCtD
Telaprevir—Asthenia—Doxorubicin—kidney cancer	2.97e-05	0.000348	CcSEcCtD
Telaprevir—Pruritus—Doxorubicin—kidney cancer	2.93e-05	0.000344	CcSEcCtD
Telaprevir—Diarrhoea—Doxorubicin—kidney cancer	2.83e-05	0.000332	CcSEcCtD
Telaprevir—Dizziness—Doxorubicin—kidney cancer	2.74e-05	0.000321	CcSEcCtD
Telaprevir—Vomiting—Doxorubicin—kidney cancer	2.63e-05	0.000309	CcSEcCtD
Telaprevir—Rash—Doxorubicin—kidney cancer	2.61e-05	0.000306	CcSEcCtD
Telaprevir—Dermatitis—Doxorubicin—kidney cancer	2.61e-05	0.000306	CcSEcCtD
Telaprevir—Nausea—Doxorubicin—kidney cancer	2.46e-05	0.000288	CcSEcCtD
Telaprevir—ALB—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	2.02e-05	0.000507	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—PTGS2—kidney cancer	2e-05	0.000504	CbGpPWpGaD
Telaprevir—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	2e-05	0.000503	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—JUN—kidney cancer	1.99e-05	0.000501	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—PTEN—kidney cancer	1.98e-05	0.000498	CbGpPWpGaD
Telaprevir—ALB—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	1.95e-05	0.00049	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—ANXA2—kidney cancer	1.94e-05	0.000489	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—SLC5A3—kidney cancer	1.94e-05	0.000489	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—ATP7B—kidney cancer	1.94e-05	0.000489	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—KRAS—kidney cancer	1.92e-05	0.000484	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—KCNMA1—kidney cancer	1.86e-05	0.000468	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—KRAS—kidney cancer	1.85e-05	0.000464	CbGpPWpGaD
Telaprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	1.84e-05	0.000463	CbGpPWpGaD
Telaprevir—CTSS—Immune System—KIT—kidney cancer	1.81e-05	0.000456	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—HIF1A—kidney cancer	1.81e-05	0.000456	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TSC2—kidney cancer	1.81e-05	0.000455	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—IGF2—kidney cancer	1.8e-05	0.000453	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	1.78e-05	0.000448	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—IL2—kidney cancer	1.77e-05	0.000446	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—PIK3CA—kidney cancer	1.77e-05	0.000444	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	1.77e-05	0.000444	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—MAPK3—kidney cancer	1.76e-05	0.000443	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—GSTT1—kidney cancer	1.76e-05	0.000443	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	1.74e-05	0.000438	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—KDR—kidney cancer	1.74e-05	0.000436	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ACY1—kidney cancer	1.73e-05	0.000436	CbGpPWpGaD
Telaprevir—CTSK—Immune System—RAF1—kidney cancer	1.73e-05	0.000435	CbGpPWpGaD
Telaprevir—CTSK—Immune System—RELA—kidney cancer	1.72e-05	0.000433	CbGpPWpGaD
Telaprevir—CTSK—Immune System—ERBB2—kidney cancer	1.71e-05	0.00043	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	1.7e-05	0.000428	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	1.7e-05	0.000428	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	1.7e-05	0.000428	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—VEGFA—kidney cancer	1.7e-05	0.000428	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—PIK3CA—kidney cancer	1.7e-05	0.000427	CbGpPWpGaD
Telaprevir—CTSK—Immune System—MTOR—kidney cancer	1.69e-05	0.000425	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CD4—kidney cancer	1.69e-05	0.000424	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—MAPK1—kidney cancer	1.68e-05	0.000422	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CDH1—kidney cancer	1.67e-05	0.00042	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—PTGS1—kidney cancer	1.65e-05	0.000415	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—GRB7—kidney cancer	1.62e-05	0.000408	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—kidney cancer	1.62e-05	0.000408	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—APC—kidney cancer	1.6e-05	0.000402	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—KIT—kidney cancer	1.6e-05	0.000402	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CDKN1B—kidney cancer	1.58e-05	0.000398	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—KRAS—kidney cancer	1.58e-05	0.000398	CbGpPWpGaD
Telaprevir—CTSK—Immune System—IL2—kidney cancer	1.55e-05	0.00039	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—POMC—kidney cancer	1.52e-05	0.000383	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—KRAS—kidney cancer	1.52e-05	0.000382	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ACY1—kidney cancer	1.52e-05	0.000382	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—ITPR2—kidney cancer	1.51e-05	0.000379	CbGpPWpGaD
Telaprevir—CTSK—Immune System—JUN—kidney cancer	1.51e-05	0.000379	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—VEGFA—kidney cancer	1.51e-05	0.000379	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—BRAF—kidney cancer	1.5e-05	0.000378	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—TP53—kidney cancer	1.5e-05	0.000377	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CTNNB1—kidney cancer	1.5e-05	0.000376	CbGpPWpGaD
Telaprevir—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	1.49e-05	0.000375	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.48e-05	0.000372	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PDHB—kidney cancer	1.47e-05	0.000371	CbGpPWpGaD
Telaprevir—CTSK—Immune System—PTEN—kidney cancer	1.46e-05	0.000367	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—PIK3CA—kidney cancer	1.46e-05	0.000366	CbGpPWpGaD
Telaprevir—CTSS—Immune System—RAF1—kidney cancer	1.42e-05	0.000358	CbGpPWpGaD
Telaprevir—CTSS—Immune System—RELA—kidney cancer	1.42e-05	0.000356	CbGpPWpGaD
Telaprevir—CTSS—Immune System—ERBB2—kidney cancer	1.41e-05	0.000354	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—PIK3CA—kidney cancer	1.4e-05	0.000351	CbGpPWpGaD
Telaprevir—CTSS—Immune System—MTOR—kidney cancer	1.39e-05	0.00035	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CD4—kidney cancer	1.39e-05	0.000349	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CCBL1—kidney cancer	1.39e-05	0.000348	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CDKN1B—kidney cancer	1.31e-05	0.000328	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PDHB—kidney cancer	1.29e-05	0.000325	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IL2—kidney cancer	1.28e-05	0.000321	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—RAF1—kidney cancer	1.25e-05	0.000315	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.25e-05	0.000315	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—RELA—kidney cancer	1.25e-05	0.000314	CbGpPWpGaD
Telaprevir—CTSK—Immune System—MAPK3—kidney cancer	1.25e-05	0.000313	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	1.24e-05	0.000313	CbGpPWpGaD
Telaprevir—CTSS—Immune System—JUN—kidney cancer	1.24e-05	0.000312	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—ERBB2—kidney cancer	1.24e-05	0.000312	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CTNNB1—kidney cancer	1.23e-05	0.00031	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MTOR—kidney cancer	1.23e-05	0.000308	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—GSTP1—kidney cancer	1.22e-05	0.000307	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CCBL1—kidney cancer	1.21e-05	0.000305	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1.2e-05	0.000303	CbGpPWpGaD
Telaprevir—CTSS—Immune System—PTEN—kidney cancer	1.2e-05	0.000302	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GLIPR1—kidney cancer	1.2e-05	0.000302	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PPAT—kidney cancer	1.2e-05	0.000302	CbGpPWpGaD
Telaprevir—CTSK—Immune System—MAPK1—kidney cancer	1.19e-05	0.000298	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.19e-05	0.000298	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.17e-05	0.000295	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CDKN1B—kidney cancer	1.15e-05	0.000289	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IL2—kidney cancer	1.13e-05	0.000283	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.12e-05	0.000282	CbGpPWpGaD
Telaprevir—CTSK—Immune System—KRAS—kidney cancer	1.12e-05	0.000282	CbGpPWpGaD
Telaprevir—ALB—Metabolism—APRT—kidney cancer	1.12e-05	0.000281	CbGpPWpGaD
Telaprevir—ALB—Metabolism—FH—kidney cancer	1.12e-05	0.000281	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IFNA1—kidney cancer	1.11e-05	0.000279	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.11e-05	0.000278	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CCND1—kidney cancer	1.1e-05	0.000276	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—JUN—kidney cancer	1.09e-05	0.000275	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.09e-05	0.000274	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CTNNB1—kidney cancer	1.09e-05	0.000273	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.06e-05	0.000267	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PTEN—kidney cancer	1.06e-05	0.000266	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GLIPR1—kidney cancer	1.05e-05	0.000265	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PPAT—kidney cancer	1.05e-05	0.000265	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GPC3—kidney cancer	1.05e-05	0.000264	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.05e-05	0.000264	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IFNA2—kidney cancer	1.03e-05	0.000259	CbGpPWpGaD
Telaprevir—CTSK—Immune System—PIK3CA—kidney cancer	1.03e-05	0.000259	CbGpPWpGaD
Telaprevir—CTSS—Immune System—MAPK3—kidney cancer	1.03e-05	0.000258	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.03e-05	0.000258	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CA2—kidney cancer	1.02e-05	0.000257	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ALAD—kidney cancer	9.96e-06	0.00025	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	9.91e-06	0.000249	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	9.9e-06	0.000249	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—APRT—kidney cancer	9.79e-06	0.000246	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—FH—kidney cancer	9.79e-06	0.000246	CbGpPWpGaD
Telaprevir—CTSS—Immune System—MAPK1—kidney cancer	9.77e-06	0.000246	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	9.76e-06	0.000245	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ST3GAL2—kidney cancer	9.72e-06	0.000244	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	9.66e-06	0.000243	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—VEGFA—kidney cancer	9.56e-06	0.00024	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ALDH1A1—kidney cancer	9.5e-06	0.000239	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	9.44e-06	0.000237	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ACY1—kidney cancer	9.36e-06	0.000235	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IGF2—kidney cancer	9.29e-06	0.000233	CbGpPWpGaD
Telaprevir—CTSS—Immune System—KRAS—kidney cancer	9.23e-06	0.000232	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GPC3—kidney cancer	9.2e-06	0.000231	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PGK1—kidney cancer	9.11e-06	0.000229	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SLC5A3—kidney cancer	9.11e-06	0.000229	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MAPK3—kidney cancer	9.04e-06	0.000227	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	8.98e-06	0.000226	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CA2—kidney cancer	8.95e-06	0.000225	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	8.94e-06	0.000225	CbGpPWpGaD
Telaprevir—ALB—Metabolism—LDHB—kidney cancer	8.93e-06	0.000224	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	8.89e-06	0.000223	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MYC—kidney cancer	8.8e-06	0.000221	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ALAD—kidney cancer	8.72e-06	0.000219	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	8.68e-06	0.000218	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MAPK1—kidney cancer	8.61e-06	0.000216	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	8.53e-06	0.000214	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ST3GAL2—kidney cancer	8.51e-06	0.000214	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	8.51e-06	0.000214	CbGpPWpGaD
Telaprevir—CTSS—Immune System—PIK3CA—kidney cancer	8.48e-06	0.000213	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	8.45e-06	0.000212	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ALDH1A1—kidney cancer	8.32e-06	0.000209	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	8.24e-06	0.000207	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—KRAS—kidney cancer	8.13e-06	0.000204	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PGK1—kidney cancer	7.98e-06	0.000201	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SLC5A3—kidney cancer	7.98e-06	0.000201	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PDHB—kidney cancer	7.96e-06	0.0002	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—POMC—kidney cancer	7.93e-06	0.000199	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—LDHB—kidney cancer	7.82e-06	0.000197	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	7.82e-06	0.000197	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CA9—kidney cancer	7.74e-06	0.000195	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.57e-06	0.00019	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	7.55e-06	0.00019	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CCBL1—kidney cancer	7.48e-06	0.000188	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PIK3CA—kidney cancer	7.47e-06	0.000188	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	7.44e-06	0.000187	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TP53—kidney cancer	7.22e-06	0.000182	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	7.15e-06	0.00018	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	7.04e-06	0.000177	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	6.84e-06	0.000172	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	6.8e-06	0.000171	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CA9—kidney cancer	6.78e-06	0.000171	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	6.7e-06	0.000168	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CRABP1—kidney cancer	6.58e-06	0.000166	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GLIPR1—kidney cancer	6.49e-06	0.000163	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PPAT—kidney cancer	6.49e-06	0.000163	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	6.32e-06	0.000159	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ITPR2—kidney cancer	6.12e-06	0.000154	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—FH—kidney cancer	6.03e-06	0.000152	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—APRT—kidney cancer	6.03e-06	0.000152	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	5.9e-06	0.000148	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	5.81e-06	0.000146	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CRABP1—kidney cancer	5.77e-06	0.000145	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GPC3—kidney cancer	5.67e-06	0.000143	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.64e-06	0.000142	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	5.62e-06	0.000141	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTT1—kidney cancer	5.58e-06	0.00014	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ACHE—kidney cancer	5.58e-06	0.00014	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CA2—kidney cancer	5.52e-06	0.000139	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ALAD—kidney cancer	5.37e-06	0.000135	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ITPR2—kidney cancer	5.36e-06	0.000135	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SCARB1—kidney cancer	5.28e-06	0.000133	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ST3GAL2—kidney cancer	5.25e-06	0.000132	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PTGS1—kidney cancer	5.23e-06	0.000131	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PSMD7—kidney cancer	5.13e-06	0.000129	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ALDH1A1—kidney cancer	5.13e-06	0.000129	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—RAF1—kidney cancer	5.11e-06	0.000128	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PGK1—kidney cancer	4.92e-06	0.000124	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SLC5A3—kidney cancer	4.92e-06	0.000124	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ACHE—kidney cancer	4.89e-06	0.000123	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTT1—kidney cancer	4.89e-06	0.000123	CbGpPWpGaD
Telaprevir—ALB—Metabolism—BCHE—kidney cancer	4.86e-06	0.000122	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—LDHB—kidney cancer	4.82e-06	0.000121	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SLC5A5—kidney cancer	4.8e-06	0.000121	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SLC2A1—kidney cancer	4.64e-06	0.000117	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SCARB1—kidney cancer	4.63e-06	0.000116	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PTGS1—kidney cancer	4.58e-06	0.000115	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IL2—kidney cancer	4.58e-06	0.000115	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.5e-06	0.000113	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PSMD7—kidney cancer	4.49e-06	0.000113	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	4.42e-06	0.000111	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—BCHE—kidney cancer	4.26e-06	0.000107	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SLC5A5—kidney cancer	4.21e-06	0.000106	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CA9—kidney cancer	4.18e-06	0.000105	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SLC2A1—kidney cancer	4.06e-06	0.000102	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.92e-06	9.87e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—VEGFA—kidney cancer	3.89e-06	9.79e-05	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.88e-06	9.74e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTP1—kidney cancer	3.87e-06	9.73e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—MAPK3—kidney cancer	3.68e-06	9.26e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ABCB1—kidney cancer	3.66e-06	9.21e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTM1—kidney cancer	3.56e-06	8.94e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CRABP1—kidney cancer	3.55e-06	8.93e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—MAPK1—kidney cancer	3.5e-06	8.81e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTP1—kidney cancer	3.39e-06	8.52e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP1A1—kidney cancer	3.37e-06	8.47e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—KRAS—kidney cancer	3.31e-06	8.32e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ITPR2—kidney cancer	3.3e-06	8.31e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTM1—kidney cancer	3.12e-06	7.83e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CA—kidney cancer	3.04e-06	7.65e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTT1—kidney cancer	3.01e-06	7.57e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ACHE—kidney cancer	3.01e-06	7.57e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP1A1—kidney cancer	2.95e-06	7.42e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TP53—kidney cancer	2.94e-06	7.4e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SCARB1—kidney cancer	2.85e-06	7.17e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PTGS1—kidney cancer	2.82e-06	7.1e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.77e-06	6.96e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PSMD7—kidney cancer	2.77e-06	6.96e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—BCHE—kidney cancer	2.62e-06	6.6e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.59e-06	6.52e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—POMC—kidney cancer	2.51e-06	6.32e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.5e-06	6.29e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—POMC—kidney cancer	2.2e-06	5.53e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTP1—kidney cancer	2.09e-06	5.25e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PTGS2—kidney cancer	2e-06	5.04e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ABCB1—kidney cancer	1.98e-06	4.97e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTM1—kidney cancer	1.92e-06	4.82e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.82e-06	4.57e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PTGS2—kidney cancer	1.76e-06	4.41e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PTEN—kidney cancer	1.75e-06	4.39e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PTEN—kidney cancer	1.53e-06	3.85e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—POMC—kidney cancer	1.36e-06	3.41e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CA—kidney cancer	1.23e-06	3.1e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PTGS2—kidney cancer	1.08e-06	2.72e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CA—kidney cancer	1.08e-06	2.72e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PTEN—kidney cancer	9.44e-07	2.37e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CA—kidney cancer	6.66e-07	1.67e-05	CbGpPWpGaD
